Luminex Corporation Acquires EraGen Biosciences, Inc.

We represented Luminex Corporation in its acquisition of privately held EraGen Biosciences, Inc. an innovator in molecular diagnostic testing techniques for infectious disease and genetic applications. The acquisition was valued at $34 million.

Luminex Corporation (NASDAQ: LMNX) develops, manufactures and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.

You Also May Be Interested In: